Remote Disease-Area Clinician: Trial Endpoints & Prescribing

Weekday AI; United States; Remote; USD 207,000 - 317,000; Part time

Job summary

Weekday AI is seeking US-based practicing physicians to contribute to an expert evaluation project focused on drug development and commercial programs. As a Disease-Area Clinician, you will review endpoints, interpret trial results, and assess whether study findings will influence prescribing decisions and real-world practice within your therapeutic area.

This is a fully remote engagement for board-certified physicians with latest clinical practice, approximately 10–20 hours over 1–2 weeks, paid

Qualifications

• MD/DO with active US clinical practice and board certification.
• Familiarity with biotechnology and pharmaceutical drug development.
• Ability to translate complex evidence into structured written reasoning.

Responsibilities

• Develop and critically review evaluation rubrics for commercial drugs and drug-development programs.
• Interpret clinical trial endpoints, study results, and efficacy/safety data.
• Assess whether trial findings are meaningful to practicing physicians.
• Evaluate whether trial outcomes may influence prescribing decisions and clinical practice.
• Assess potential impact of evidence on real-world treatment adoption.
• Provide clear evidence-based reasoning behind clinical assessments and recommendations.
• Collaborate with subject-matter experts to ensure rigor and consistency.

Skills

End-to-end clinical evaluation

Clinical trial interpretation

Evidence-based prescribing

Medical writing clarity

Education

MD or DO with active clinical practice in the United States

Board certification in a relevant medical specialty

Active, unrestricted medical licensure in the United States

Job description

Weekday AI is seeking US-based practicing physicians to contribute to an expert evaluation project focused on drug development and commercial programs. As a Disease-Area Clinician, you will review endpoints, interpret trial results, and assess whether study findings will influence prescribing decisions and real-world practice within your therapeutic area.

This is a fully remote engagement for board-certified physicians with latest clinical practice, approximately 10–20 hours over 1–2 weeks, paid